Biology:Oncotherm
Oncotherm medical devices are produced by Oncotherm Ltd. and used for cancer treatment.
Methodology
The company's methodology is based on the view of its founder that the heat-dose sensitive characterization of tissue is at the core of the oncothermia treatment.[1] The tumor tissue has lower impedance than the surrounding tissues,[citation needed] so most of the energy is transmitted and absorbed by the cancerous lesion. This selection of the tumor tissues (self-focusing) renders external focusing unnecessary.[2]
Company
Oncotherm Ltd. was founded in 1988 by Prof. Dr. András Szász[3] in Hungary. In 2002, it received investment from a Germany company and was reorganized as a German-Hungarian company consisting of Oncotherm Hungary Ltd[4] and Oncotherm GmbH.[5]
Medical devices
Their main products are the Oncotherm EHY-2000[6] and the Oncotherm EHY-2030,[7] hyperthermia devices using the thermoelectric effects of electrical fields.
More than 450 devices have been placed into operation, mostly in Germany and South Korea , and performed over 400,000 treatments.[8] The devices are not approved by the U.S. Food and Drug Administration.[citation needed]
References
- ↑ Szasz A (2007). "Hyperthermia, a modality in the wings". J Cancer Res Ther 3 (1): 56–66. doi:10.4103/0973-1482.31976. PMID 17998724.
- ↑ "Oncothermia method | Oncotherm". https://oncotherm.com/en/oncothermia-method.
- ↑ aiadmin. "Prof. András Szász" (in en-US). http://szaszandras.hu/.
- ↑ "OncoTherm Kft céginformáció, cégkivonat, cégmásolat". https://i.creditonline.hu/hu/oncotherm-kft/13091251958.
- ↑ "Contact Us | Oncotherm". https://oncotherm.com/en/contact-us.
- ↑ "EHY-2000plus | Oncotherm". https://oncotherm.com/en/products/ehy-2000plus.
- ↑ "EHY-2030 | Oncotherm". https://oncotherm.com/hu/products/ehy-2030.
- ↑ Oncotherm Official site
 |  |
